RxDoctor Payments Data

Calvin Reams, MD

Family Medicine · Thomasville, GANPI 1427131101

Payments from drug & device makers

$2,399in general payments, 2019–2025

Across 130 payments — averaging $18.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$454
  • Dexcom, Inc.$336
  • Pfizer$238
  • GSK$226
  • AbbVie$155
  • Almatica Pharma LLC$113
  • plus $876 from 23 others

What the payments were for

  • Food & beverage$2,399100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,399 in reported general payments places this provider in the 70th percentile of 3,111 family medicine providers in Georgia.

See all family medicine providers in Georgia

Medicare billing

Part B allowed, 2024
$79,065
Medicare patients
180
Services billed
4,619

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin82$78,344
EliquisApixaban46$65,190
OzempicSemaglutide59$56,222
JanuviaSitagliptin Phosphate43$45,793
MyrbetriqMirabegron74$44,792
FarxigaDapagliflozin Propanediol21$30,714
EntrestoSacubitril/Valsartan19$17,409
RybelsusSemaglutide14$15,584
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog13$15,357
FycompaPerampanel13$15,211
XareltoRivaroxaban18$13,641
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog11$11,637
ShingrixVaricella-Zoster Ge/As01b/Pf34$7,550
TrintellixVortioxetine Hydrobromide15$6,780
Breo ElliptaFluticasone/Vilanterol12$4,661

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$19$78,34482 claims
Novo NordiskOzempic, Rybelsus$454$71,80673 claims
PfizerEliquis$238$65,19046 claims
Astellas Pharma US IncMyrbetriq$75$44,79274 claims
AstraZenecaFarxiga$29$30,71421 claims
NovartisEntresto$24$17,40919 claims
Johnson & JohnsonXarelto$34$13,64118 claims
GSKShingrix, Breo Ellipta$226$12,21246 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$42$6,78015 claims
Almatica Pharma LLCSertraline Hcl$113$1,378114 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 3,111 family medicine providers in Georgia.

Other family medicine in Thomasville

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →